Taiwan: Pfizer stumped by royalty-free licence

09-05-2016

Victor Lee and Jesse Peng

Last year, the Taiwan Intellectual Property Court issued a judgment (101-CPL-112) holding that the patentee in an exclusive licensing deal in which no royalties have been paid has no standing to sue for patent infringement.


Victor Lee and Jesse Peng, Tsai, Lee & Chen, Pfizer, Patent Act, Viagra,

WIPR